You just read:

DelMar Formalizes Collaboration with PRA Health Sciences for Phase 3 Trial of VAL-083 in Recurrent Glioblastoma Multiforme (GBM)

News provided by

DelMar Pharmaceuticals, Inc.

May 11, 2017, 08:30 ET